Navigation Links
SurgiQuest, Inc. Secures $19 Million to Fund Commercialization and Launch the Next Generation Access Technology Cited by Surgeons as The Future of Minimally Invasive Surgery
Date:7/8/2011

ORANGE, Conn., July 8, 2011 /PRNewswire/ -- SurgiQuest, Inc. ("SurgiQuest", the "Company") today announced that the Company has closed a $19 million round of financing from both current and new investors. River Cities Capital Funds of Cincinnati, Ohio led the round followed by Fletcher Spaght Ventures of Boston, Massachusetts. Additional investments from CMEA Ventures, California Technology Ventures, LLC, Aphelion Medical Fund and other existing SurgiQuest investors completed the round. SurgiQuest will utilize the capital from the latest round to respond to increasing demand for its products and drive commercialization initiatives domestically and abroad.

SurgiQuest's patented AirSeal® Access System provides unprecedented access to the abdominal cavity during minimally invasive surgery ("MIS"). Unlike conventional insufflation and trocar systems, the Company's breakthrough integrated platform assures stable pneumoperitoneum, continuously evacuates smoke and plume when energized medical devices such as electrocautery, laser or ultrasound are used, and provides valve-free access to the abdominal cavity during both laparoscopic and robotic surgical procedures.

SurgiQuest's unique and unconventional product solutions enable improved MIS approaches in both laparoscopic and DaVinci® Robotic surgical procedures.

"We appreciate the faith and ongoing support that our current and new investors have shown in our technology, our people and our vision for the exciting future ahead. This funding will be used to expand growth and move us toward profitability," stated Mr. Kurt Azarbarzin, Founder and CEO of SurgiQuest. "Our organization is extremely optimistic and energized as we approach on the expansion of our breakthrough AirSeal® technology to the entire field of laparoscopic surgery."

About SurgiQuest

SurgiQuest, Inc. is a privately held venture-backed company, founded in May 2006. The Company develops, manufactures and markets innovative access technology for minimally invasive surgery.

Additional information about SurgiQuest products can be found at www.surgiquest.com.

About River Cities Capital Funds

River Cities Capital Funds is one of the most active and experienced venture funds investing in the Midwest and Southeastern United States. With $390 million under management and over 75 investments over fourteen years, River Cities has established itself as a preferred partner among the regional entrepreneurial and broader venture capital communities. For more information, visit www.rccf.com.

About Fletcher Spaght Ventures

Fletcher Spaght Ventures, L.P. is a venture capital firm investing in emerging growth healthcare and high technology companies.  Fletcher Spaght focuses on healthcare companies, including: medical devices, life science tools, biotechnology, and healthcare services; and on high technology including: information technology (IT) and IT services, Internet and e-commerce, software computer and network hardware, and communications. Additionally, Fletcher Spaght targets "convergence" opportunities that span both healthcare and IT such as MEMS in cardiac devices, software ASP in radiology and digital imaging in dentistry.  For more information, visit www.fletcherspaght.com.

CONTACT:  Gary Tegan, +1-612-889-9490


'/>"/>
SOURCE SurgiQuest, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Digital Assent Secures $7.5 Million Series B Funding
2. Precyse Secures Healthcare IT Executive Chris Powell as New President
3. Ethicon, Inc. Announces Availability of ETHICON SECURESTRAP™ 5mm Absorbable Strap Fixation Device
4. Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh
5. KellBenx Secures Exclusive Worldwide License With AdnaGen for Commercializing Patented Antibodies
6. MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film
7. Core Essence Secures $11.5 Million Series B Financing
8. CardioFocus Secures $5M Credit Facility with Silicon Valley Bank
9. Vystar® Corporation Secures a $3M Credit Facility to Fund Growth
10. Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation
11. PLC Systems Secures $4 Million in Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student from ... in Educational Leadership and Administration at St. Thomas University in Miami, Florida, was ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... and more products at customers’ doorstep. According to Smart Mart, customers can now ... stated to offer wearable, and customers can find clothing at discounted prices. Apart ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):